Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Cipla
Express Scripts
US Army
Federal Trade Commission
McKinsey

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 7,153,505

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,153,505
Title:Methods for enlarging the diameter of an artery or vein in a human subject
Abstract: The invention provides methods for treating an obstructed biological conduit that include administering to the conduit an agent that can degrade extracellular matrix of obstructing tissue. Particular methods include delivery of an enzyme or a mixture of several enzymes to the area or region of obstruction wherein the enzyme(s) have the capability to degrade extracellular matrix components within the obstruction thereby restoring the normal flow of transported fluid through the conduit. The invention also includes preventively dilating a section of conduit to minimize the risk of obstruction formation.
Inventor(s): Franano; F. Nicholas (Kansas City, MO)
Assignee: Proteon Therapeutics, Inc. (Kansas City, MO)
Application Number:10/603,501
Patent Claims:see list of patent claims

Details for Patent 7,153,505

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04 ➤ Sign Up Proteon Therapeutics, Inc. (Kansas City, MO) 2019-09-24 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,153,505

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 0121574 Dec 27, 2002
World Intellectual Property Organization (WIPO) 0121574 Mar 29, 2001
United States of America 10179163 Jan 15, 2019
United States of America 2004265294 Dec 30, 2004
United States of America 2007014781 Jan 18, 2007
United States of America 2007014782 Jan 18, 2007
United States of America 2008317736 Dec 25, 2008
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Moodys
Merck
McKesson
US Army
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.